Table 2 Comparison of various factors among two groups of grossly peripheral IHCC patients classified by SSTR2 and Bcl2 expression
Factors | p-Group P (n = 14) | p-Group H (n = 16) | p value |
|---|---|---|---|
Gender (M/F) | 9/5 | 12/4 | 0.405 |
Age (years old) | 68.7 ± 2.4 | 71.3 ± 2.2 | 0.221 |
Hepatic virus infection (−/+) | 9/5 | 12/4 | 0.405 |
Curability (A, B/C) | 14/0 | 10/6 | 0.031 |
T (1, 2/3, 4) | 9/5 | 2/14 | 0.005 |
N (0/1–3) | 13/1 | 10/6 | 0.061 |
cStage (I, II/III, IV) | 9/5 | 1/15 | 0.001 |
Tumor type (MF/MF + PI) | 11/3 | 4/12 | 0.005 |
Differentiation (Cholangiolo/tub1/others) | 5/3/6 | 0/8/8 | 0.009 |
Tumor thrombus in the portal vain (−/+) | 11/3 | 14/2 | 0.426 |
Tumor thrombus in the hepatic vain (−/+) | 12/2 | 14/2 | 0.482 |
Intrahepatic metastasis (−/+) | 12/2 | 14/2 | 0.482 |
Tumor thrombus in the bile duct (−/+) | 10/4 | 7/9 | 0.391 |
CEA†(ng/dL) (< 5/> 5) | 11/3 | 11/5 | 0.426 |
CA19-9‡ (U/mL) (< 100/> 100) | 10/4 | 7/9 | 0.972 |